Innovative "Diamond Shaped" 3D Printed Microfluidic Devices for Lysozyme-Loaded Liposomes

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2022 Nov 26

PMID 36432675

Authors

Federica Sommonte

Edward Weaver

Essyrose Mathew

Nunzio Denora

Dimitrios A Lamprou

Affiliations

Soon will be listed here.

Abstract

Nanotechnology applications have emerged as one of the most actively researched areas in recent years. As a result, substantial study into nanoparticulate lipidic systems and liposomes (LPs) has been conducted. Regardless of the advantages, various challenges involving traditional manufacturing processes have hampered their expansion. Here, the combination of microfluidic technology (MF) and 3D printing (3DP) digital light processing (DLP) was fruitfully investigated in the creation of novel, previously unexplored "diamond shaped" devices suitable for the production of LPs carrying lysozyme as model drug. Computer-aided design (CAD) software was used designing several MF devices with significantly multiple and diverse geometries. These were printed using a high-performance DLP 3DP, resulting in extremely high-resolution chips that were tested to optimize the experimental condition of MF-based LPs. Monodisperse narrow-sized lysozyme-loaded PEGylated LPs were produced using in-house devices. The developed formulations succumbed to stability tests to determine their consistency, and then an encapsulation efficacy (EE) study was performed, yielding good findings. The in vitro release study indicated that lysozyme-loaded LPs could release up to 93% of the encapsulated cargo within 72 h. Therefore, the proficiency of the association between MF and 3DP was demonstrated, revealing a potential growing synergy.

Citing Articles

Fabrication of Biomimetic Hybrid Liposomes via Microfluidic Technology: Homotypic Targeting and Antitumor Efficacy Studies in Glioma Cells.

Arduino I, Di Fonte R, Sommonte F, Lopedota A, Porcelli L, Li J Int J Nanomedicine. 2024; 19:13217-13233.

PMID: 39679250 PMC: 11638480. DOI: 10.2147/IJN.S489872.

Paclitaxel-loaded elastic liposomes synthesised by microfluidics technique for enhance transdermal delivery.

Jaradat E, Meziane A, Lamprou D Drug Deliv Transl Res. 2024; 15(4):1265-1283.

PMID: 39020246 PMC: 11870984. DOI: 10.1007/s13346-024-01672-0.

Exploiting Pharma 4.0 Technologies in the Non-Biological Complex Drugs Manufacturing: Innovations and Implications.

Malheiro V, Duarte J, Veiga F, Mascarenhas-Melo F Pharmaceutics. 2023; 15(11).

PMID: 38004525 PMC: 10674941. DOI: 10.3390/pharmaceutics15112545.

Synthesis and Characterization of Paclitaxel-Loaded PEGylated Liposomes by the Microfluidics Method.

Jaradat E, Weaver E, Meziane A, Lamprou D Mol Pharm. 2023; 20(12):6184-6196.

PMID: 37931072 PMC: 10698720. DOI: 10.1021/acs.molpharmaceut.3c00596.

Rapid Production of Nanoscale Liposomes Using a 3D-Printed Reactor-In-A-Centrifuge: Formulation, Characterisation, and Super-Resolution Imaging.

He Y, De Grandi D, Chandradoss S, Lutheryn G, Cidonio G, Bastos R Micromachines (Basel). 2023; 14(9).

PMID: 37763926 PMC: 10535575. DOI: 10.3390/mi14091763.

References

Haidar Z, Hamdy R, Tabrizian M . Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes. Biomaterials. 2007; 29(9):1207-15. DOI: 10.1016/j.biomaterials.2007.11.012. View

Kara A, Vassiliadou A, Ongoren B, Keeble W, Hing R, Lalatsa A . Engineering 3D Printed Microfluidic Chips for the Fabrication of Nanomedicines. Pharmaceutics. 2021; 13(12). PMC: 8706109. DOI: 10.3390/pharmaceutics13122134. View

Briuglia M, Rotella C, McFarlane A, Lamprou D . Influence of cholesterol on liposome stability and on in vitro drug release. Drug Deliv Transl Res. 2015; 5(3):231-42. DOI: 10.1007/s13346-015-0220-8. View

Roces C, Lou G, Jain N, Abraham S, Thomas A, Halbert G . Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics. Pharmaceutics. 2020; 12(11). PMC: 7697682. DOI: 10.3390/pharmaceutics12111095. View

Morgenstern J, Baumann P, Brunner C, Hubbuch J . Effect of PEG molecular weight and PEGylation degree on the physical stability of PEGylated lysozyme. Int J Pharm. 2017; 519(1-2):408-417. DOI: 10.1016/j.ijpharm.2017.01.040. View

Arduino I, Liu Z, Rahikkala A, Figueiredo P, Correia A, Cutrignelli A . Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique. Acta Biomater. 2020; 121:566-578. DOI: 10.1016/j.actbio.2020.12.024. View

Musgrove H, Catterton M, Pompano R . Applied tutorial for the design and fabrication of biomicrofluidic devices by resin 3D printing. Anal Chim Acta. 2022; 1209:339842. PMC: 9454328. DOI: 10.1016/j.aca.2022.339842. View

Bottger R, Pauli G, Chao P, Al Fayez N, Hohenwarter L, Li S . Lipid-based nanoparticle technologies for liver targeting. Adv Drug Deliv Rev. 2020; 154-155:79-101. DOI: 10.1016/j.addr.2020.06.017. View

Park H, Otte A, Park K . Evolution of drug delivery systems: From 1950 to 2020 and beyond. J Control Release. 2021; 342:53-65. PMC: 8840987. DOI: 10.1016/j.jconrel.2021.12.030. View

10.

Maeki M, Fujishima Y, Sato Y, Yasui T, Kaji N, Ishida A . Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers. PLoS One. 2017; 12(11):e0187962. PMC: 5705116. DOI: 10.1371/journal.pone.0187962. View

11.

Jaradat E, Weaver E, Meziane A, Lamprou D . Microfluidic paclitaxel-loaded lipid nanoparticle formulations for chemotherapy. Int J Pharm. 2022; 628:122320. DOI: 10.1016/j.ijpharm.2022.122320. View

12.

Krkobabic M, Medarevic D, Cvijic S, Grujic B, Ibric S . Hydrophilic excipients in digital light processing (DLP) printing of sustained release tablets: Impact on internal structure and drug dissolution rate. Int J Pharm. 2019; 572:118790. DOI: 10.1016/j.ijpharm.2019.118790. View

13.

Elsana H, Olusanya T, Carr-Wilkinson J, Darby S, Faheem A, Elkordy A . Evaluation of novel cationic gene based liposomes with cyclodextrin prepared by thin film hydration and microfluidic systems. Sci Rep. 2019; 9(1):15120. PMC: 6805922. DOI: 10.1038/s41598-019-51065-4. View

14.

Nielsen A, Beauchamp M, Nordin G, Woolley A . 3D Printed Microfluidics. Annu Rev Anal Chem (Palo Alto Calif). 2019; 13(1):45-65. PMC: 7282950. DOI: 10.1146/annurev-anchem-091619-102649. View

15.

Mathew E, Pitzanti G, Larraneta E, Lamprou D . 3D Printing of Pharmaceuticals and Drug Delivery Devices. Pharmaceutics. 2020; 12(3). PMC: 7150971. DOI: 10.3390/pharmaceutics12030266. View

16.

Patra J, Das G, Fraceto L, Campos E, Del Pilar Rodriguez-Torres M, Acosta-Torres L . Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018; 16(1):71. PMC: 6145203. DOI: 10.1186/s12951-018-0392-8. View

17.

Tai K, Rappolt M, Mao L, Gao Y, Yuan F . Stability and release performance of curcumin-loaded liposomes with varying content of hydrogenated phospholipids. Food Chem. 2020; 326:126973. DOI: 10.1016/j.foodchem.2020.126973. View

18.

Forbes N, Hussain M, Briuglia M, Edwards D, Ter Horst J, Szita N . Rapid and scale-independent microfluidic manufacture of liposomes entrapping protein incorporating in-line purification and at-line size monitoring. Int J Pharm. 2018; 556:68-81. DOI: 10.1016/j.ijpharm.2018.11.060. View

19.

Martins J, Torrieri G, Santos H . The importance of microfluidics for the preparation of nanoparticles as advanced drug delivery systems. Expert Opin Drug Deliv. 2018; 15(5):469-479. DOI: 10.1080/17425247.2018.1446936. View

20.

Carugo D, Bottaro E, Owen J, Eleanor Stride , Nastruzzi C . Liposome production by microfluidics: potential and limiting factors. Sci Rep. 2016; 6:25876. PMC: 4872163. DOI: 10.1038/srep25876. View